Search research articles
Contact Us
Filters
Showing results (401-410 of 412) with videos related to
Page
of 42
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 1, 2024
Bioreactor-produced iPSCs-derived dopaminergic neuron-containing neural microtissues innervate and normalize rotational bias in a dose-dependent manner in a Parkinson rat model
Nicolas Prudon, Lucía Cordero-Espinoza, Myriam Abarkan, et al.
Blood
|
April 10, 2016
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms
Anouk Emadali, Neda Hoghoughi, Samuel Duley, et al.
The Journal of Clinical Investigation
|
August 12, 2020
Type 2 diabetes risk gene Dusp8 regulates hypothalamic Jnk signaling and insulin sensitivity
Sonja C Schriever, Dhiraj G Kabra, Katrin Pfuhlmann, et al.
NEJM Evidence
|
June 24, 2025
Intermediate-Dose Cytarabine as Postinduction AML Therapy
Mathilde Hunault, Cécile Pautas, Sarah Bertoli, et al.
European Journal of Haematology
|
March 25, 2021
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial
Anne Bouvier, Jean-François Hamel, Jacques Delaunay, et al.
Leukemia
|
May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement
Benoit Ducourneau, Arnaud Pages, Stéphanie Struski, et al.
Leukemia
|
October 14, 2006
Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique
B Cauwelier, H Cavé, C Gervais, et al.
Blood Advances
|
October 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, et al.
Blood
|
May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy
Nicolas Duployez, Romane Joudinaud, Augustin Boudry, et al.
Journal of Advanced Research
|
December 30, 2022
CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury
Matthieu Leuillier, Thomas Duflot, Séverine Ménoret, et al.
Page
of 42
Search research articles
Search
Showing results (401-410 of 412) with videos related to
Sort By:
Page
of 42
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 1, 2024
Bioreactor-produced iPSCs-derived dopaminergic neuron-containing neural microtissues innervate and normalize rotational bias in a dose-dependent manner in a Parkinson rat model
Nicolas Prudon, Lucía Cordero-Espinoza, Myriam Abarkan, et al.
Blood
|
April 10, 2016
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms
Anouk Emadali, Neda Hoghoughi, Samuel Duley, et al.
The Journal of Clinical Investigation
|
August 12, 2020
Type 2 diabetes risk gene Dusp8 regulates hypothalamic Jnk signaling and insulin sensitivity
Sonja C Schriever, Dhiraj G Kabra, Katrin Pfuhlmann, et al.
NEJM Evidence
|
June 24, 2025
Intermediate-Dose Cytarabine as Postinduction AML Therapy
Mathilde Hunault, Cécile Pautas, Sarah Bertoli, et al.
European Journal of Haematology
|
March 25, 2021
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial
Anne Bouvier, Jean-François Hamel, Jacques Delaunay, et al.
Leukemia
|
May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement
Benoit Ducourneau, Arnaud Pages, Stéphanie Struski, et al.
Leukemia
|
October 14, 2006
Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique
B Cauwelier, H Cavé, C Gervais, et al.
Blood Advances
|
October 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, et al.
Blood
|
May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy
Nicolas Duployez, Romane Joudinaud, Augustin Boudry, et al.
Journal of Advanced Research
|
December 30, 2022
CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury
Matthieu Leuillier, Thomas Duflot, Séverine Ménoret, et al.
Page
of 42